Olij Rozen International BV has been acquired by Dümmen Orange
The shareholders of Olij Rozen International BV (Olij) have sold the company to Dümmen Orange. Financial details have not been disclosed.
Olij is a global specialist in the field of breeding, propagation, growing and marketing of cut and pot roses. In addition to its own varieties, the company propagates, grows and markets varieties for third parties. Olij is present in the Netherlands, Ethiopia, Kenya, Ecuador, Colombia and Mexico. The company also operates a network of agents and sales representatives with global coverage.
Dümmen Orange is a leading company in the breeding and development of cut flowers, pot plants, bedding plants, bulbs, succulents and perennials. The company has a US$200 million turnover and employs more than 6,000 people worldwide. In addition to a large marketing and sales network, Dümmen Orange has a strong network of production sites supported by a global supply chain.
Oaklins' team in the Netherlands advised the seller in this transaction.
Talk to the deal team
Related deals
Hemink Groep has been acquired by Gimv
Gimv has acquired a majority stake in Hemink, a Dutch specialist in real estate renovation and maintenance. This transaction marks a new chapter for Hemink, as it seeks to expand its position as a national leader in sustainable property services through its new partnership with Gimv.
Learn moreOGD has been sold to Building Beyond Technology Group
Building Beyond Technology Group (BBTG) strengthens its position in the IT sector by welcoming OGD IT-Dienstverlening (OGD) to its platform. With over 1,400 employees, OGD is an established name in the Dutch market as a mission-critical IT service provider for large-scale clients. This addition not only increases BBTG’s scale but also enhances its domain expertise and execution capabilities through close cooperation with the other platform companies.
Learn moreThe Providence Projects has been acquired by UKAT Group
Celebrity-success rehabilitation center, The Providence Projects, has joined The UK Addiction Treatment (UKAT) Group, backed by Sullivan Street Equity Partners.
Learn more